Hydroxychloroquine is “useless” against Covid-19: Oxford Professor
Team Udayavani, Jun 7, 2020, 12:57 PM IST
UK has halted a major drug trial after British scientists found that the anti-malarial hydroxychloroquine, was “useless” at treating Covid- 19 patients
The trial run by the University of Oxford has stopped enrolling patients with immediate effect saying “hydroxychloroquine does not benefit hospitalised Covid-19 patients” and “it did not reduce the risk of death.”
The Chief Investigators of the Randomised Evaluation of Covid-19 Therapy (RECOVERY) trial in UK, said a total of 1542 patients were randomised to hydroxychloroquine and compared with 3132 patients who were on usual care.
There was no significant difference in mortality benefits of those who took HCQ and those who did not.
Martin Landray, an Oxford University professor who is co-leading the RECOVERY trial, said, “This is not a treatment for COVID-19. It doesn’t work. This result should change medical practice worldwide. We can now stop using a drug that is useless.”
Earlier, Lancet raised safety concerns which led several Covid-19 studies of it to be halted. However, the Lancet study was then retracted on Thursday after its authors said they were unsure about its data.
But now the preliminary results from RECOVERY are quite clear and states that hydroxychloroquine does not reduce the risk of death among hospitalised patients with Covid-19.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Surgical options for Parkinson’s disease
Breast cancer to cause a million deaths a year by 2040: Lancet commission
Will to resist temptations, achieve goals more trustworthy than using apps, study finds
Govt directs e-commerce firms to remove drinks, beverages from ‘health drinks’ category
Experiencing abuse, neglect as child linked to lifelong ill-health: Study
MUST WATCH
Latest Additions
BJP too echoes ‘JP-JP’ chorus in Udupi-Chikkamagalur: Cong leader Niketraj Maurya
Sanjay Singh warns of conspiracy against Kejriwal, fears for his safety in jail
Remarks on Allopathy: SC asks Ramdev to implead complainants in his plea for stay of criminal probes
Thane man loses Rs 38 lakh in share-trading scam, case registered
Women voters outnumber men in all 5 Assam LS seats where voting is underway